By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

The New England Journal of Medicine 

10 Shattuck Street

Boston  Massachusetts  02115-6094  U.S.A.
Phone: 617-734-9800 Fax: 617-739-9864


SEARCH JOBS


Industry
Services

Segment
Publisher





Company News
Avidity Biosciences Announces Publication On Targeting Therapeutic Oligonucleotides By Arthur A. Levin In The New England Journal of Medicine 1/5/2017 6:52:09 AM
Kite Pharma (KITE) Announces Publication Of T-Cell Therapy Targeting Mutant KRAS In Cancer By The NCI In The New England Journal of Medicine 12/12/2016 10:33:13 AM
Oxford Immunotec (OXFD) Announces The New England Journal of Medicine Publication On Clinical Trial Results Of Serological And Nucleic Acid Tests For Babesia In Blood Screening 12/8/2016 11:26:48 AM
PALOMA-2 Phase 3 Study Published In The New England Journal of Medicine Demonstrates Clinical Benefit Of Pfizer (PFE)’s IBRANCE(palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer 11/17/2016 11:43:09 AM
Janssen Pharmaceutical Companies Release: Phase 3 Study Results Supporting U.S. FDA And European Commission (EC) Approvals Of STELARA In The Treatment Of Moderately To Severely Active Crohn's Disease Published In The New England Journal of Medicine 11/17/2016 7:17:31 AM
Alnylam (ALNY) And The Medicines Company (MDCO) Announce Publication Of Phase 1 Clinical Data With Inclisiran (ALN- PCSsc) In The New England Journal of Medicine 11/14/2016 12:24:27 PM
Advanced Accelerator Applications Release: Biotech Announces The New England Journal of Medicine Publication Of Lutathera NETTER-1 Phase III Results 10/28/2016 2:15:08 PM
The New England Journal of Medicine Publishes Study On Zika Genomic Sequence Identification By IDbyDNA 9/29/2016 8:22:50 AM
GlaxoSmithKline (GSK) And Innoviva Release: Positive Results From The COPD Salford Lung Study Published In The The New England Journal of Medicine And Presented At European Respiratory Congress 9/6/2016 1:34:34 PM
Agendia BV Release: The New England Journal of Medicine Publishes MINDACT Trial Results Proving The Clinical Utility Of Mammaprint In Assisting Physicians To Identify Early-Stage Breast Cancer Patients Who Can Safely Forgo Chemotherapy 8/25/2016 8:49:21 AM
12345678910...
//-->